There is described an isocyanate-based polymer foam having the combination of: (i) a Limiting Oxygen Index (LOI) of greater than or equal to 26.5% when measured pursuant to ASTM D2863-17a, and (ii) a Total Volatile Organic Content (TVOC) when measured pursuant to VDA 277 of less than or equal to 225 μg/g C. Preferably, the foam is produced from a foamable composition comprising: an isocyanate; a reactive compound containing: (1) at least one hydrogen which is reactive with the isocyanate, and (2) one or both of a halogen and a phosphate moiety; a blowing agent comprising one or both of water and carbon dioxide; and a catalyst; wherein the reactive compound is present in an amount in the range of from about 30% to about 95% of total ISO equivalents excluding water, if present in the foamable composition.

A method for producing a polyurethane according to the present invention including: a first step wherein an epoxy carboxylate compound (X) is obtained by reacting (a) an epoxy compound that includes a halogen atom content of 10 ppm by mass or less, while having only two epoxy groups and no hydroxyl group in each molecule, (b) an unsaturated aliphatic monocarboxylic acid that has an ethylenic unsaturated group in each molecule, while having no aromatic ring, and (c) an aromatic monocarboxylic acid that has no ethylenic unsaturated group in each molecule; and a second step wherein the epoxy carboxylate compound (X) obtained in the first step is reacted with a diisocyanate compound (Y).

Tumor resection is commonly practiced to prevent the progression of cancer. However, there are post-surgery concerns including the formation of a void that can allow cancer cells to escape at the surgery site, which increases the risk of metastasis. To counter this challenge, an embodiment includes a polyurethane-based shape memory foam as a tissue void-filling device that can also release anti-cancer drugs. Such foams may activate at body temperature and become malleable. Such properties may enable the foam to be shaped to precisely seal the tissue void and then serve as a drug-eluting device. Based on the drug composition with poly vinyl alcohol (PVA), the drug release profile from the foam may be altered depending on the application.

The invention relates to a crosslinkable fluorinated urethane compound having at least one ethylenically unsaturated functional group. Such compounds are useful as coatings additives such that, when the coating is applied to a substrate, the additive compound is allowed to first migrate to the surface and subsequently crosslink to form a durable oil-, dirt-, and water-repellent surface.

The invention relates to a crosslinkable fluorinated urethane compound having at least one ethylenically unsaturated functional group. Such compounds are useful as coatings additives such that, when the coating is applied to a substrate, the additive compound is allowed to first migrate to the surface and subsequently crosslink to form a durable oil-, dirt-, and water-repellent surface.

A polymer having a repeating unit represented by Formula 1:

##STR00001## wherein each of R.sub.1, R.sub.2, and R.sub.3 is independently selected from a substituted or unsubstituted C1-C6 chain-like saturated or unsaturated hydrocarbon group having 0 to 2 first heteroatoms or a substituted or unsubstituted C3-C6 cyclic saturated or unsaturated hydrocarbon group having 0 to 2 first heteroatoms, wherein at least one of R.sub.1, R.sub.2, and R.sub.3 is a hydrocarbon group substituted with a fluorine atom. R.sub.4 is a C1-C10 chain-like saturated or unsaturated hydrocarbon group having 0 to 2 second heteroatoms or a C3-C10 cyclic saturated or unsaturated hydrocarbon group having 0 to 2 second heteroatoms. R.sub.5 is a C1-C10 chain-like saturated or unsaturated hydrocarbon group having 1 to 6 third heteroatoms or a C3-C10 cyclic saturated or unsaturated hydrocarbon group having 1 to 6 third heteroatoms.

Polymers containing halogen functionality are prepared by the addition or condensation polymerization of at least one halogenated reactant containing at least two active hydrogen-containing functional groups per molecule and at least one halogenated heteroalkyl or halogenated heteroalkenyl group per molecule and at least one co-reactant containing at least two functional groups reactive with the active hydrogen groups of the at least one halogenated reactant.

The invention relates to a crosslinkable fluorinated urethane compound having at least one ethylenically unsaturated functional group. Such compounds are useful as coatings additives such that, when the coating is applied to a substrate, the additive compound is allowed to first migrate to the surface and subsequently crosslink to form a durable oil-, dirt-, and water-repellent surface.

A surface protecting resin member includes a cured product of a composition containing an acrylic resin having a hydroxyl value within the range of 40 mgKOH/g to 280 mgKOH/g, a polyol having a hydroxyl value within the range of 40 mgKOH/g to 300 mgKOH/g, a multifunctional isocyanate, and a fluorotelomer alcohol represented by the following general formula CF.sub.3(CF.sub.2).sub.n(CH.sub.2).sub.mOH, where n is an integer of 1 or more and m is an integer within the range of 1 to 4.

The invention relates to a crosslinkable fluorinated urethane compound having at least one ethylenically unsaturated functional group. Such compounds are useful as coatings additives such that, when the coating is applied to a substrate, the additive compound is allowed to first migrate to the surface and subsequently crosslink to form a durable oil-, dirt-, and water-repellent surface.